New Frontiers in Measuring and Characterizing the HIV Reservoir

A cure for HIV infection remains elusive due to the persistence of replication-competent HIV proviral DNA during suppressive antiretroviral therapy (ART). With the exception of rare elite or post-treatment controllers of viremia, withdrawal of ART invariably results in the rebound of viremia and pro...

Full description

Bibliographic Details
Main Authors: Shane D. Falcinelli, Cristina Ceriani, David M. Margolis, Nancie M. Archin
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-12-01
Series:Frontiers in Microbiology
Subjects:
HIV
Online Access:https://www.frontiersin.org/article/10.3389/fmicb.2019.02878/full
id doaj-6ac190cb08ca49fcbcab8136c0cab08b
record_format Article
spelling doaj-6ac190cb08ca49fcbcab8136c0cab08b2020-11-25T01:17:07ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2019-12-011010.3389/fmicb.2019.02878491401New Frontiers in Measuring and Characterizing the HIV ReservoirShane D. Falcinelli0Shane D. Falcinelli1Cristina Ceriani2Cristina Ceriani3David M. Margolis4David M. Margolis5David M. Margolis6Nancie M. Archin7Nancie M. Archin8UNC HIV Cure Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United StatesDepartment of Microbiology and Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United StatesUNC HIV Cure Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United StatesDepartment of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United StatesUNC HIV Cure Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United StatesDepartment of Microbiology and Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United StatesDepartment of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United StatesUNC HIV Cure Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United StatesDepartment of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United StatesA cure for HIV infection remains elusive due to the persistence of replication-competent HIV proviral DNA during suppressive antiretroviral therapy (ART). With the exception of rare elite or post-treatment controllers of viremia, withdrawal of ART invariably results in the rebound of viremia and progression of HIV disease. A thorough understanding of the reservoir is necessary to develop new strategies in order to reduce or eliminate the reservoir. However, there is significant heterogeneity in the sequence composition, genomic location, stability, and expression of the HIV reservoir both within and across individuals, and a majority of proviral sequences are replication-defective. These factors, and the low frequency of persistently infected cells in individuals on suppressive ART, make understanding the reservoir and its response to experimental reservoir reduction interventions challenging. Here, we review the characteristics of the HIV reservoir, state-of-the-art assays to measure and characterize the reservoir, and how these assays can be applied to accurately detect reductions in reservoir during efforts to develop a cure for HIV infection. In particular, we highlight recent advances in the development of direct measures of provirus, including intact proviral DNA assays and full-length HIV DNA sequencing with integration site analysis. We also focus on novel techniques to quantitate persistent and inducible HIV, including RNA sequencing and RNA/gag protein staining techniques, as well as modified viral outgrowth methods that seek to improve upon throughput, sensitivity and dynamic range.https://www.frontiersin.org/article/10.3389/fmicb.2019.02878/fullHIVcurereservoirstabilityreplication-competentdefective provirus
collection DOAJ
language English
format Article
sources DOAJ
author Shane D. Falcinelli
Shane D. Falcinelli
Cristina Ceriani
Cristina Ceriani
David M. Margolis
David M. Margolis
David M. Margolis
Nancie M. Archin
Nancie M. Archin
spellingShingle Shane D. Falcinelli
Shane D. Falcinelli
Cristina Ceriani
Cristina Ceriani
David M. Margolis
David M. Margolis
David M. Margolis
Nancie M. Archin
Nancie M. Archin
New Frontiers in Measuring and Characterizing the HIV Reservoir
Frontiers in Microbiology
HIV
cure
reservoir
stability
replication-competent
defective provirus
author_facet Shane D. Falcinelli
Shane D. Falcinelli
Cristina Ceriani
Cristina Ceriani
David M. Margolis
David M. Margolis
David M. Margolis
Nancie M. Archin
Nancie M. Archin
author_sort Shane D. Falcinelli
title New Frontiers in Measuring and Characterizing the HIV Reservoir
title_short New Frontiers in Measuring and Characterizing the HIV Reservoir
title_full New Frontiers in Measuring and Characterizing the HIV Reservoir
title_fullStr New Frontiers in Measuring and Characterizing the HIV Reservoir
title_full_unstemmed New Frontiers in Measuring and Characterizing the HIV Reservoir
title_sort new frontiers in measuring and characterizing the hiv reservoir
publisher Frontiers Media S.A.
series Frontiers in Microbiology
issn 1664-302X
publishDate 2019-12-01
description A cure for HIV infection remains elusive due to the persistence of replication-competent HIV proviral DNA during suppressive antiretroviral therapy (ART). With the exception of rare elite or post-treatment controllers of viremia, withdrawal of ART invariably results in the rebound of viremia and progression of HIV disease. A thorough understanding of the reservoir is necessary to develop new strategies in order to reduce or eliminate the reservoir. However, there is significant heterogeneity in the sequence composition, genomic location, stability, and expression of the HIV reservoir both within and across individuals, and a majority of proviral sequences are replication-defective. These factors, and the low frequency of persistently infected cells in individuals on suppressive ART, make understanding the reservoir and its response to experimental reservoir reduction interventions challenging. Here, we review the characteristics of the HIV reservoir, state-of-the-art assays to measure and characterize the reservoir, and how these assays can be applied to accurately detect reductions in reservoir during efforts to develop a cure for HIV infection. In particular, we highlight recent advances in the development of direct measures of provirus, including intact proviral DNA assays and full-length HIV DNA sequencing with integration site analysis. We also focus on novel techniques to quantitate persistent and inducible HIV, including RNA sequencing and RNA/gag protein staining techniques, as well as modified viral outgrowth methods that seek to improve upon throughput, sensitivity and dynamic range.
topic HIV
cure
reservoir
stability
replication-competent
defective provirus
url https://www.frontiersin.org/article/10.3389/fmicb.2019.02878/full
work_keys_str_mv AT shanedfalcinelli newfrontiersinmeasuringandcharacterizingthehivreservoir
AT shanedfalcinelli newfrontiersinmeasuringandcharacterizingthehivreservoir
AT cristinaceriani newfrontiersinmeasuringandcharacterizingthehivreservoir
AT cristinaceriani newfrontiersinmeasuringandcharacterizingthehivreservoir
AT davidmmargolis newfrontiersinmeasuringandcharacterizingthehivreservoir
AT davidmmargolis newfrontiersinmeasuringandcharacterizingthehivreservoir
AT davidmmargolis newfrontiersinmeasuringandcharacterizingthehivreservoir
AT nanciemarchin newfrontiersinmeasuringandcharacterizingthehivreservoir
AT nanciemarchin newfrontiersinmeasuringandcharacterizingthehivreservoir
_version_ 1725148142797586432